Cervical cancer occurs when abnormal cells in the cervix, the narrow passage connecting the uterus to the vagina, become cancerous. Because the process by which cells go through precancerous changes and finally become malignant typically occurs slowly, cervical cancer often can be prevented or treated in its earliest stages, when there is the strongest likelihood of a good outcome.
The oncologists and other medical professionals at Regional Cancer Care Associates are equipped with the latest knowledge, technology, and techniques to treat cervical cancer effectively. With 25 convenient, community-based locations throughout New Jersey, Connecticut, and the Washington, D.C., area, our offices provide the personalized and trusted health services patients deserve.
There are a few signs that may indicate the early phase, or Stage 1, of cervical cancer. This is the stage when cancerous cells are present in small numbers. These symptoms include, but aren’t limited to:
These symptoms may be indicative of a number of gynecologic or other conditions rather than cervical cancer, but they merit prompt evaluation by a gynecologist or healthcare professional. Conversely, women with early-stage cervical cancer may not experience any symptoms, which is why it is important to have regular cervical screening tests – such as a Pap smear or cervical liquid-based cytology test – to identify the presence of abnormal cells or cancer in the cervix.
In more-advanced cases of cervical cancer, when the disease has spread throughout the cervix or has reached other parts of the body, symptoms may include:
Other symptoms may occur, as well. Once more, while these symptoms may reflect many causes other than cervical cancer, all need to be evaluated promptly by a healthcare professional.
There are many steps women can take to lower their risk of developing cervical cancer. For instance, routine cervical screening tests are vital to the detection and early treatment of precancerous conditions and cervical cancer. The earlier the disease is found, the sooner the patient can obtain treatment and the greater the survival rate. The five-year survival rate for all individuals who contract cervical cancer is 66%.
Conversely, some factors may increase a patient’s risk for developing cervical cancer, making preventative measures important to their health. These factors include:
Preventing infection with HPV, which is linked to the development of cervical cancer, and other sexually transmitted diseases, such as human immunodeficiency virus (HIV) and chlamydia, can greatly reduce the chances of cervical cancer occurring.
Eliminating cigarette smoking or exposure to second-hand smoke is another way to reduce the risk of developing cervical cancer. Smoking has been associated with an increased rate of the cancer.
Some evidence indicates that long-term use of oral contraceptives can heighten the risk of cervical cancer. Meanwhile, women who have had three or more full-term pregnancies may also have an increased risk of developing cancer of the cervix. It is important to talk with an Ob/Gyn or other gynecologic healthcare provider regarding the latest evidence on these subjects.
The optimal treatment strategy for cervical cancer depends on many factors, including the stage of the cancer and the person’s age and overall health. If cervical cancer is in Stage II to Stage IV, treatment options include:
Radiation therapy is one of the most common ways to treat cancer, including cervical malignancies. It employs high-energy rays to destroy cancer cells. Frequently, radiation therapy is administered in conjunction with other cancer treatments, such as surgery and chemotherapy.
Chemotherapy use cytotoxic drugs to kill cancerous cells. They drugs are injected intravenously or taken orally in pill form. Chemotherapy has been shown to shrink tumors and kill cancer cells that may remain after surgery or radiation treatment.
There are many types of surgery to remove cancerous cervical cells, with the choice of procedure based largely on the stage of cancer. Laser surgery is frequently used to treat precancerous cells and early-stage cervical cancer. Sometimes hysterectomy, or removal of the uterus, is necessary to treat cervical cancer.
Immunotherapies harness the power of the body’s immune system to identify and destroy cancerous cells. Immunotherapy may be used to treat cervical cancer that has spread extensively throughout the body or that has recurred after earlier treatment.
Targeted therapy involves the use of drugs that seek out and destroy cancerous cells with specific genetic mutations. These drugs target the cancerous cells and leave healthy cells intact. This is a newer treatment that is a component of precision medicine.
The oncologists and hematologists of Regional Cancer Care Associates believe that early detection and diagnosis of cervical cancer is the ideal pathway to the most effective treatment. Our experienced team serves patients with various cancers and blood disorders in offices located in New Jersey, Connecticut, Massachusetts, and the Washington, D.C., area. Contact us today to learn more about cervical cancer risks, receive the latest treatments, obtain cancer care support, or request an appointment.
Although you’re not alone in facing cervical cancer, no other woman shares your unique combination of health status, lifestyle, family situation and age. For these and many other reasons, your care at RCCA is equally unique. From your first appointment, through treatment, while managing side effects and during post-treatment care, your RCCA team will be dedicated to your very individual journey back to good health.
For more information, or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
More than 80 medical oncologists and hematologists affiliated with Regional Cancer Care Associates (RCCA) – one of the nation’s largest networks of oncology specialists — are on the frontlines of the fight against cancer in New Jersey, providing care to well over 100,000 people each year in 19 community-based practices across the Garden State.
While prostate cancer can affect men of any racial or ethnic background, it poses a particular threat to Black men.
Bhavesh Balar, MD, says that a dramatic increase in cancer treatment options and the prolonged survival those regimens are providing lend new urgency to an old challenge: effective communication between oncologists and their patients’ other physicians.
When standard cancer treatments aren’t providing the results you want, clinical trials may offer hope. Our physicians use clinical trials to study new treatments, helping transform cancer care for the better. You can enroll in a clinical trial to try groundbreaking treatment plans at zero cost to you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.
